The Medicine Maker | The Medicine Maker

Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics

August 31, 2026

New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products

4 min read

Cell & Gene

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

Development & Clinical

Musings from The Power List: Christine Allen

Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise

Biopharma

The Hidden Complexity of Stability Storage

Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong

Biopharma

Green Shoots, Gray Skies

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Biopharma Industry News Development & Clinical Drug Discovery

Phase III Success Marks Milestone for Personalized Cancer Vaccines

August 26, 2026

Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field

7 min read

Drug Discovery Business & Trends

Data Quality: Drug Discovery AI’s Indispensable Foundation

August 25, 2026

Reliable discovery insights depend on models grounded in curated, verifiable scientific knowledge

5 min read

Cell & Gene Industry News Research News

This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells

August 24, 2026

A new preservation method could remove a major barrier to treatment, the FDA approves the first gene therapy for GSDIa, and ultrasound directs CAR T cells toward solid tumors

5 min read

Cell & Gene Development & Clinical Business & Trends Power List Technology & Manufacturing

The Biggest Bottlenecks Holding Back Cell and Gene Therapy

August 24, 2026

Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges

9 min read

Interviews Business & Trends

What Pharma Can Learn From Military Intelligence

August 21, 2026

Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence

5 min read

Small Molecules Drug Discovery Development & Clinical Interviews Power List

Musings from The Power List: Daniel Vitt

August 20, 2026

From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development

6 min read

Cell & Gene Development & Clinical Interviews Technology & Manufacturing

The Road to Commercial-Scale iPSC Cell Therapy

August 19, 2026

Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?

5 min read

Biopharma Development & Clinical Outsourcing Regulation & Standards Interviews Business & Trends

The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

10 min read

Cell & Gene Industry News Research News

This Week’s CGT News: T-Cell Therapy Clears Pediatric Solid Tumor

August 17, 2026

PRAME-targeted T cells produce a complete response in metastatic nephroblastoma, CAR T cells remain active after a decade, and an in vivo CRISPR screen identifies edits that strengthen solid-tumor activity

3 min read

Biopharma Technology & Manufacturing

Biopharma Labs Have an Integration Debt Problem

August 17, 2026

Biopharma labs are investing heavily in digital tools, but without trusted data architecture, each new platform can add another point of failure

5 min read

Top Stories